Niihara Yutaka 4
4 · Emmaus Life Sciences, Inc. · Filed Jan 17, 2023
Insider Transaction Report
Form 4
Niihara Yutaka
DirectorChairman and CEO10% Owner
Transactions
- Award
Warrants (right to buy)
2023-01-12$4.50/sh+7,500,000$33,750,000→ 0 totalExercise: $4.50From: 2023-01-12Exp: 2028-01-11→ Common Stock (7,500,000 underlying)